Whole Shine Medical Technology Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Whole Shine Medical Technology.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Healthcare earnings growth	22.9%
Revenue growth rate	n/a
Future return on equity	n/a
Analyst coverage	None
Last updated	n/a

Recent future growth updates

No updates

Recent updates

Further Upside For Whole Shine Medical Technology Co., Ltd. (SZSE:002622) Shares Could Introduce Price Risks After 36% Bounce

Oct 01

Whole Shine Medical Technology (SZSE:002622) Is Experiencing Growth In Returns On Capital

Aug 26

Whole Shine Medical Technology Co., Ltd. (SZSE:002622) Stock's 27% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Jul 21

Not Many Are Piling Into Whole Shine Medical Technology Co., Ltd. (SZSE:002622) Stock Yet As It Plummets 27%

Jun 05

Why We're Not Concerned Yet About Whole Shine Medical Technology Co., Ltd.'s (SZSE:002622) 28% Share Price Plunge

Apr 21

Shareholders Should Be Pleased With Whole Shine Medical Technology Co., Ltd.'s (SZSE:002622) Price

Mar 05

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Whole Shine Medical Technology has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

SZSE:002622 - Analysts future estimates and past financials data (CNY Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
9/30/2024	868	-97	103	134	N/A
6/30/2024	825	-101	96	126	N/A
3/31/2024	791	-98	89	122	N/A
12/31/2023	757	-94	103	137	N/A
9/30/2023	613	-227	55	83	N/A
6/30/2023	602	-219	58	86	N/A
3/31/2023	548	-232	41	68	N/A
1/1/2023	501	-257	8	32	N/A
9/30/2022	503	-91	-8	3	N/A
6/30/2022	331	-116	-32	-23	N/A
3/31/2022	234	-98	-24	-18	N/A
12/31/2021	168	-76	13	18	N/A
9/30/2021	133	-268	43	43	N/A
6/30/2021	134	-255	58	59	N/A
3/31/2021	122	-299	63	63	N/A
12/31/2020	114	-297	65	65	N/A
9/30/2020	116	-6	72	72	N/A
6/30/2020	117	-10	55	55	N/A
3/31/2020	124	16	43	42	N/A
12/31/2019	155	7	23	23	N/A
9/30/2019	234	3	-55	-48	N/A
6/30/2019	321	20	-19	-11	N/A
3/31/2019	435	36	-35	-23	N/A
12/31/2018	422	37	-8	4	N/A
9/30/2018	381	60	14	27	N/A
6/30/2018	317	49	N/A	-126	N/A
3/31/2018	209	58	N/A	-139	N/A
12/31/2017	195	72	N/A	-167	N/A
9/30/2017	149	19	N/A	-193	N/A
6/30/2017	150	34	N/A	-69	N/A
3/31/2017	124	18	N/A	-49	N/A
12/31/2016	120	16	N/A	-33	N/A
9/30/2016	116	60	N/A	15	N/A
6/30/2016	114	59	N/A	-1	N/A
3/31/2016	139	81	N/A	6	N/A
12/31/2015	147	90	N/A	16	N/A
9/30/2015	162	79	N/A	-6	N/A
6/30/2015	153	70	N/A	49	N/A
3/31/2015	158	56	N/A	80	N/A
12/31/2014	161	47	N/A	60	N/A
9/30/2014	157	32	N/A	76	N/A
6/30/2014	165	33	N/A	71	N/A
3/31/2014	176	38	N/A	53	N/A
12/31/2013	185	39	N/A	69	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 002622's forecast earnings growth is above the savings rate (2.8%).

Earnings vs Market: Insufficient data to determine if 002622's earnings are forecast to grow faster than the CN market

High Growth Earnings: Insufficient data to determine if 002622's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if 002622's revenue is forecast to grow faster than the CN market.

High Growth Revenue: Insufficient data to determine if 002622's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if 002622's Return on Equity is forecast to be high in 3 years time

Whole Shine Medical Technology Future Growth

Future criteria checks 0/6

Key information

Recent future growth updates

Recent updates

Third quarter 2024 earnings released: EPS: CN¥0.014 (vs CN¥0.01 in 3Q 2023)

Further Upside For Whole Shine Medical Technology Co., Ltd. (SZSE:002622) Shares Could Introduce Price Risks After 36% Bounce

Whole Shine Medical Technology Co., Ltd. to Report Q3, 2024 Results on Oct 31, 2024

New major risk - Share price stability

Whole Shine Medical Technology (SZSE:002622) Is Experiencing Growth In Returns On Capital

Whole Shine Medical Technology Co., Ltd. (SZSE:002622) Stock's 27% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Whole Shine Medical Technology Co., Ltd. to Report First Half, 2024 Results on Aug 30, 2024

New minor risk - Share price stability

Not Many Are Piling Into Whole Shine Medical Technology Co., Ltd. (SZSE:002622) Stock Yet As It Plummets 27%

New minor risk - Financial data availability

Whole Shine Medical Technology Co., Ltd., Annual General Meeting, May 20, 2024

Why We're Not Concerned Yet About Whole Shine Medical Technology Co., Ltd.'s (SZSE:002622) 28% Share Price Plunge

New minor risk - Share price stability

Whole Shine Medical Technology Co., Ltd. to Report Q1, 2024 Results on Apr 29, 2024

Now 23% undervalued after recent price drop

Shareholders Should Be Pleased With Whole Shine Medical Technology Co., Ltd.'s (SZSE:002622) Price

Now 28% undervalued after recent price drop

Now 26% undervalued after recent price drop

Whole Shine Medical Technology Co., Ltd. to Report Fiscal Year 2023 Results on Apr 29, 2024

Third quarter 2023 earnings released: EPS: CN¥0.01 (vs CN¥0.02 in 3Q 2022)

Second quarter 2023 earnings released: EPS: CN¥0.011 (vs CN¥0.006 loss in 2Q 2022)

Whole Shine Medical Technology Co., Ltd., Annual General Meeting, May 23, 2023

First quarter 2023 earnings released: CN¥0.001 loss per share (vs CN¥0.03 loss in 1Q 2022)

High number of new and inexperienced directors

Third quarter 2022 earnings released: EPS: CN¥0.02 (vs CN¥0.008 loss in 3Q 2021)

Rongyu Group Co., Ltd. announced that it expects to receive CNY 652 million in funding

Second quarter 2022 earnings released: CN¥0.006 loss per share (vs CN¥0.015 profit in 2Q 2021)

First quarter 2022 earnings released: CN¥0.03 loss per share (vs CN¥0.004 loss in 1Q 2021)

High number of new and inexperienced directors

Third quarter 2021 earnings released: CN¥0.008 loss per share (vs CN¥0.006 profit in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.015 (vs CN¥0.038 loss in 2Q 2020)

Rongyu Group Co., Ltd. (SZSE:002622) signed a framework agreement to acquire 52% stake in Guangzhou Delun Medical Investment Co., Ltd. from Gongqingcheng Delun Medical Investment Management Partnership (Limited Partnership).

Rongyu to Buy 67% Stake in Healthcare Firm for Up to 441.5 Mln Yuan

Full year 2020 earnings released: CN¥0.34 loss per share (vs CN¥0.009 profit in FY 2019)

New 90-day low: CN¥2.13

New 90-day low: CN¥2.79

New 90-day high: CN¥3.63

Third quarter earnings released

New 90-day low: CN¥3.03

First half earnings released

Rongyu Group Co., Ltd. to Report First Half, 2020 Results on Aug 28, 2020

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies